Bank of New York Mellon Corp - LEGEND BIOTECH CORP ownership

LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 139 filers reported holding LEGEND BIOTECH CORP in Q4 2021. The put-call ratio across all filers is 1.87 and the average weighting 0.5%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of LEGEND BIOTECH CORP
ValueSharesWeighting
Q3 2023$9,584,286
-6.5%
142,687
-3.9%
0.00%0.0%
Q2 2023$10,249,091
+35.8%
148,473
-5.1%
0.00%0.0%
Q1 2023$7,544,742
+3.3%
156,465
+6.9%
0.00%0.0%
Q4 2022$7,304,694
+253.1%
146,328
+188.5%
0.00%
+100.0%
Q3 2022$2,069,000
-6.3%
50,714
+26.3%
0.00%0.0%
Q2 2022$2,208,000
+60.3%
40,140
+5.9%
0.00%
Q1 2022$1,377,000
-7.1%
37,900
+19.2%
0.00%
Q4 2021$1,482,00031,8000.00%
Other shareholders
LEGEND BIOTECH CORP shareholders Q4 2021
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 814,586$56,230,87217.46%
Paradigm Biocapital Advisors LP 1,805,717$124,648,6459.63%
HHLR ADVISORS, LTD. 6,436,533$444,313,8739.46%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 1,123,692$77,568,4599.09%
RA Capital Management 6,264,707$432,452,7248.16%
Tri Locum Partners LP 116,768$8,060,4953.00%
Nicholas Investment Partners, LP 593,167$40,946,3182.80%
E Fund Management (Hong Kong) Co., Ltd. 51,679$3,5672.66%
Avidity Partners Management LP 798,900$55,148,0671.93%
Boxer Capital, LLC 600,000$41,4181.92%
View complete list of LEGEND BIOTECH CORP shareholders